aluates Reports

$ 0.0

Automative

Global Immuno-Oncology Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-4M6134

Global Immuno Oncology Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Immuno-Oncology Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-4M6134

Report

December 2024

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Astrazeneca plc

Bristol–Myers Squibb

Eli Lilly

Roche

GlaxoSmithKline PLC

Janssen Biotech

Merck

Novartis

Pfizer Inc

Sanofi

Spectrum Pharmaceuticals

Takeda

Immuno-Oncology Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Immuno-Oncology Treatment Market

Market Analysis and Insights: Global Immuno-Oncology Treatment Market

The global Immuno-Oncology Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Immuno-Oncology Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Immuno-Oncology Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immuno-Oncology Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immuno-Oncology Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immuno-Oncology Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immuno-Oncology Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Immuno-Oncology Treatment Market Report

Report Metric	Details
Report Name	Immuno-Oncology Treatment Market
CAGR	5%
Segment by Type	Immune Checkpoint Inhibitors Monoclonal Antibodies Cytokine-Based Immunotherapy Cancer Vaccines CAR-T Cell Therapy
Segment by Application	Hospitals Ambulatory Surgical Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck, Novartis, Pfizer, Sanofi, Spectrum Pharmaceuticals, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immuno-Oncology Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Oncology Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immuno-Oncology Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Immuno-Oncology Treatment Market report?

Ans: The main players in the Immuno-Oncology Treatment Market are Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck, Novartis, Pfizer, Sanofi, Spectrum Pharmaceuticals, Takeda

What are the Application segmentation covered in the Immuno-Oncology Treatment Market report?

Ans: The Applications covered in the Immuno-Oncology Treatment Market report are Hospitals, Ambulatory Surgical Center, Others

What are the Type segmentation covered in the Immuno-Oncology Treatment Market report?

Ans: The Types covered in the Immuno-Oncology Treatment Market report are Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy

Recommended Reports

Cancer Therapeutics

Cancer Treatment Devices

Immuno-Oncology Advances

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Immune Checkpoint Inhibitors

1.2.3 Monoclonal Antibodies

1.2.4 Cytokine-Based Immunotherapy

1.2.5 Cancer Vaccines

1.2.6 CAR-T Cell Therapy

1.3 Market by Application

1.3.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Center

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immuno-Oncology Treatment Market Perspective (2019-2030)

2.2 Global Immuno-Oncology Treatment Growth Trends by Region

2.2.1 Immuno-Oncology Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immuno-Oncology Treatment Historic Market Size by Region (2019-2024)

2.2.3 Immuno-Oncology Treatment Forecasted Market Size by Region (2025-2030)

2.3 Immuno-Oncology Treatment Market Dynamics

2.3.1 Immuno-Oncology Treatment Industry Trends

2.3.2 Immuno-Oncology Treatment Market Drivers

2.3.3 Immuno-Oncology Treatment Market Challenges

2.3.4 Immuno-Oncology Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Immuno-Oncology Treatment by Players

3.1.1 Global Immuno-Oncology Treatment Revenue by Players (2019-2024)

3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Immuno-Oncology Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Immuno-Oncology Treatment Market Concentration Ratio

3.4.1 Global Immuno-Oncology Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Treatment Revenue in 2023

3.5 Global Key Players of Immuno-Oncology Treatment Head office and Area Served

3.6 Global Key Players of Immuno-Oncology Treatment, Product and Application

3.7 Global Key Players of Immuno-Oncology Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Oncology Treatment Breakdown Data by Type

4.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2019-2024)

4.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2025-2030)

5 Immuno-Oncology Treatment Breakdown Data by Application

5.1 Global Immuno-Oncology Treatment Historic Market Size by Application (2019-2024)

5.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immuno-Oncology Treatment Market Size (2019-2030)

6.2 North America Immuno-Oncology Treatment Market Size by Type

6.2.1 North America Immuno-Oncology Treatment Market Size by Type (2019-2024)

6.2.2 North America Immuno-Oncology Treatment Market Size by Type (2025-2030)

6.2.3 North America Immuno-Oncology Treatment Market Share by Type (2019-2030)

6.3 North America Immuno-Oncology Treatment Market Size by Application

6.3.1 North America Immuno-Oncology Treatment Market Size by Application (2019-2024)

6.3.2 North America Immuno-Oncology Treatment Market Size by Application (2025-2030)

6.3.3 North America Immuno-Oncology Treatment Market Share by Application (2019-2030)

6.4 North America Immuno-Oncology Treatment Market Size by Country

6.4.1 North America Immuno-Oncology Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Immuno-Oncology Treatment Market Size by Country (2019-2024)

6.4.3 North America Immuno-Oncology Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Immuno-Oncology Treatment Market Size (2019-2030)

7.2 Europe Immuno-Oncology Treatment Market Size by Type

7.2.1 Europe Immuno-Oncology Treatment Market Size by Type (2019-2024)

7.2.2 Europe Immuno-Oncology Treatment Market Size by Type (2025-2030)

7.2.3 Europe Immuno-Oncology Treatment Market Share by Type (2019-2030)

7.3 Europe Immuno-Oncology Treatment Market Size by Application

7.3.1 Europe Immuno-Oncology Treatment Market Size by Application (2019-2024)

7.3.2 Europe Immuno-Oncology Treatment Market Size by Application (2025-2030)

7.3.3 Europe Immuno-Oncology Treatment Market Share by Application (2019-2030)

7.4 Europe Immuno-Oncology Treatment Market Size by Country

7.4.1 Europe Immuno-Oncology Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Immuno-Oncology Treatment Market Size by Country (2019-2024)

7.4.3 Europe Immuno-Oncology Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Immuno-Oncology Treatment Market Size (2019-2030)

8.2 China Immuno-Oncology Treatment Market Size by Type

8.2.1 China Immuno-Oncology Treatment Market Size by Type (2019-2024)

8.2.2 China Immuno-Oncology Treatment Market Size by Type (2025-2030)

8.2.3 China Immuno-Oncology Treatment Market Share by Type (2019-2030)

8.3 China Immuno-Oncology Treatment Market Size by Application

8.3.1 China Immuno-Oncology Treatment Market Size by Application (2019-2024)

8.3.2 China Immuno-Oncology Treatment Market Size by Application (2025-2030)

8.3.3 China Immuno-Oncology Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Immuno-Oncology Treatment Market Size (2019-2030)

9.2 Asia Immuno-Oncology Treatment Market Size by Type

9.2.1 Asia Immuno-Oncology Treatment Market Size by Type (2019-2024)

9.2.2 Asia Immuno-Oncology Treatment Market Size by Type (2025-2030)

9.2.3 Asia Immuno-Oncology Treatment Market Share by Type (2019-2030)

9.3 Asia Immuno-Oncology Treatment Market Size by Application

9.3.1 Asia Immuno-Oncology Treatment Market Size by Application (2019-2024)

9.3.2 Asia Immuno-Oncology Treatment Market Size by Application (2025-2030)

9.3.3 Asia Immuno-Oncology Treatment Market Share by Application (2019-2030)

9.4 Asia Immuno-Oncology Treatment Market Size by Region

9.4.1 Asia Immuno-Oncology Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Immuno-Oncology Treatment Market Size by Region (2019-2024)

9.4.3 Asia Immuno-Oncology Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Immuno-Oncology Treatment Introduction

11.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.1.5 Amgen Recent Developments

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Immuno-Oncology Treatment Introduction

11.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.2.5 AstraZeneca Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction

11.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 Eli-Lilly

11.4.1 Eli-Lilly Company Details

11.4.2 Eli-Lilly Business Overview

11.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction

11.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.4.5 Eli-Lilly Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Immuno-Oncology Treatment Introduction

11.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.5.5 Roche Recent Developments

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Details

11.6.2 GlaxoSmithKline Business Overview

11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction

11.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.6.5 GlaxoSmithKline Recent Developments

11.7 Janssen Biotech

11.7.1 Janssen Biotech Company Details

11.7.2 Janssen Biotech Business Overview

11.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction

11.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.7.5 Janssen Biotech Recent Developments

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Immuno-Oncology Treatment Introduction

11.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.8.5 Merck Recent Developments

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Immuno-Oncology Treatment Introduction

11.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.9.5 Novartis Recent Developments

11.10 Pfizer

11.10.1 Pfizer Company Details

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Immuno-Oncology Treatment Introduction

11.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.10.5 Pfizer Recent Developments

11.11 Sanofi

11.11.1 Sanofi Company Details

11.11.2 Sanofi Business Overview

11.11.3 Sanofi Immuno-Oncology Treatment Introduction

11.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.11.5 Sanofi Recent Developments

11.12 Spectrum Pharmaceuticals

11.12.1 Spectrum Pharmaceuticals Company Details

11.12.2 Spectrum Pharmaceuticals Business Overview

11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction

11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.12.5 Spectrum Pharmaceuticals Recent Developments

11.13 Takeda

11.13.1 Takeda Company Details

11.13.2 Takeda Business Overview

11.13.3 Takeda Immuno-Oncology Treatment Introduction

11.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2019-2024)

11.13.5 Takeda Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Amgen Inc

Astrazeneca plc

Bristol–Myers Squibb

Eli Lilly

Roche

GlaxoSmithKline PLC

Janssen Biotech

Merck

Novartis

Pfizer Inc

Sanofi

Spectrum Pharmaceuticals

Takeda

List of Tables

Table 1. Global Immuno-Oncology Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Immune Checkpoint Inhibitors

Table 3. Key Players of Monoclonal Antibodies

Table 4. Key Players of Cytokine-Based Immunotherapy

Table 5. Key Players of Cancer Vaccines

Table 6. Key Players of CAR-T Cell Therapy

Table 7. Global Immuno-Oncology Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Immuno-Oncology Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Immuno-Oncology Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Immuno-Oncology Treatment Market Share by Region (2019-2024)

Table 11. Global Immuno-Oncology Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Immuno-Oncology Treatment Market Share by Region (2025-2030)

Table 13. Immuno-Oncology Treatment Market Trends

Table 14. Immuno-Oncology Treatment Market Drivers

Table 15. Immuno-Oncology Treatment Market Challenges

Table 16. Immuno-Oncology Treatment Market Restraints

Table 17. Global Immuno-Oncology Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Immuno-Oncology Treatment Revenue Share by Players (2019-2024)

Table 19. Global Top Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2023)

Table 20. Global Immuno-Oncology Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Immuno-Oncology Treatment, Headquarters and Area Served

Table 23. Global Key Players of Immuno-Oncology Treatment, Product and Application

Table 24. Global Key Players of Immuno-Oncology Treatment, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Immuno-Oncology Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Immuno-Oncology Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Immuno-Oncology Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Immuno-Oncology Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Immuno-Oncology Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Immuno-Oncology Treatment Revenue Share by Application (2019-2024)

Table 32. Global Immuno-Oncology Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Immuno-Oncology Treatment Revenue Share by Application (2025-2030)

Table 34. North America Immuno-Oncology Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Immuno-Oncology Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Immuno-Oncology Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Immuno-Oncology Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Immuno-Oncology Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Immuno-Oncology Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Immuno-Oncology Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Immuno-Oncology Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Immuno-Oncology Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Immuno-Oncology Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Immuno-Oncology Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Immuno-Oncology Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Immuno-Oncology Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Immuno-Oncology Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Immuno-Oncology Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Immuno-Oncology Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Immuno-Oncology Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Immuno-Oncology Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Immuno-Oncology Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Immuno-Oncology Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Immuno-Oncology Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Immuno-Oncology Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Immuno-Oncology Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Immuno-Oncology Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Immuno-Oncology Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Immuno-Oncology Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 66. Amgen Company Details

Table 67. Amgen Business Overview

Table 68. Amgen Immuno-Oncology Treatment Product

Table 69. Amgen Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 70. Amgen Recent Developments

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Immuno-Oncology Treatment Product

Table 74. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 75. AstraZeneca Recent Developments

Table 76. Bristol-Myers Squibb Company Details

Table 77. Bristol-Myers Squibb Business Overview

Table 78. Bristol-Myers Squibb Immuno-Oncology Treatment Product

Table 79. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 80. Bristol-Myers Squibb Recent Developments

Table 81. Eli-Lilly Company Details

Table 82. Eli-Lilly Business Overview

Table 83. Eli-Lilly Immuno-Oncology Treatment Product

Table 84. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 85. Eli-Lilly Recent Developments

Table 86. Roche Company Details

Table 87. Roche Business Overview

Table 88. Roche Immuno-Oncology Treatment Product

Table 89. Roche Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 90. Roche Recent Developments

Table 91. GlaxoSmithKline Company Details

Table 92. GlaxoSmithKline Business Overview

Table 93. GlaxoSmithKline Immuno-Oncology Treatment Product

Table 94. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 95. GlaxoSmithKline Recent Developments

Table 96. Janssen Biotech Company Details

Table 97. Janssen Biotech Business Overview

Table 98. Janssen Biotech Immuno-Oncology Treatment Product

Table 99. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 100. Janssen Biotech Recent Developments

Table 101. Merck Company Details

Table 102. Merck Business Overview

Table 103. Merck Immuno-Oncology Treatment Product

Table 104. Merck Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 105. Merck Recent Developments

Table 106. Novartis Company Details

Table 107. Novartis Business Overview

Table 108. Novartis Immuno-Oncology Treatment Product

Table 109. Novartis Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 110. Novartis Recent Developments

Table 111. Pfizer Company Details

Table 112. Pfizer Business Overview

Table 113. Pfizer Immuno-Oncology Treatment Product

Table 114. Pfizer Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 115. Pfizer Recent Developments

Table 116. Sanofi Company Details

Table 117. Sanofi Business Overview

Table 118. Sanofi Immuno-Oncology Treatment Product

Table 119. Sanofi Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 120. Sanofi Recent Developments

Table 121. Spectrum Pharmaceuticals Company Details

Table 122. Spectrum Pharmaceuticals Business Overview

Table 123. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product

Table 124. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 125. Spectrum Pharmaceuticals Recent Developments

Table 126. Takeda Company Details

Table 127. Takeda Business Overview

Table 128. Takeda Immuno-Oncology Treatment Product

Table 129. Takeda Revenue in Immuno-Oncology Treatment Business (2019-2024) & (US$ Million)

Table 130. Takeda Recent Developments

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immuno-Oncology Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Immuno-Oncology Treatment Market Share by Type: 2023 VS 2030

Figure 3. Immune Checkpoint Inhibitors Features

Figure 4. Monoclonal Antibodies Features

Figure 5. Cytokine-Based Immunotherapy Features

Figure 6. Cancer Vaccines Features

Figure 7. CAR-T Cell Therapy Features

Figure 8. Global Immuno-Oncology Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Immuno-Oncology Treatment Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Ambulatory Surgical Center Case Studies

Figure 12. Others Case Studies

Figure 13. Immuno-Oncology Treatment Report Years Considered

Figure 14. Global Immuno-Oncology Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Immuno-Oncology Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Immuno-Oncology Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Immuno-Oncology Treatment Market Share by Players in 2023

Figure 18. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2023

Figure 20. North America Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Immuno-Oncology Treatment Market Share by Type (2019-2030)

Figure 22. North America Immuno-Oncology Treatment Market Share by Application (2019-2030)

Figure 23. North America Immuno-Oncology Treatment Market Share by Country (2019-2030)

Figure 24. United States Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Immuno-Oncology Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Immuno-Oncology Treatment Market Share by Type (2019-2030)

Figure 28. Europe Immuno-Oncology Treatment Market Share by Application (2019-2030)

Figure 29. Europe Immuno-Oncology Treatment Market Share by Country (2019-2030)

Figure 30. Germany Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Immuno-Oncology Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Immuno-Oncology Treatment Market Share by Type (2019-2030)

Figure 38. China Immuno-Oncology Treatment Market Share by Application (2019-2030)

Figure 39. Asia Immuno-Oncology Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Immuno-Oncology Treatment Market Share by Type (2019-2030)

Figure 41. Asia Immuno-Oncology Treatment Market Share by Application (2019-2030)

Figure 42. Asia Immuno-Oncology Treatment Market Share by Region (2019-2030)

Figure 43. Japan Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Immuno-Oncology Treatment Market Share by Country (2019-2030)

Figure 53. Brazil Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Immuno-Oncology Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 60. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 62. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 63. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 64. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 65. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 66. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 67. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 68. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 69. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 70. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 71. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2019-2024)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immuno oncology Clinical Trials Market Research Report 2024

Global Oncology and Cancer Treatment Drug Market Research Report 2024

Global Tumor Immunity Therapy Market Research Report 2024

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

Global Asthma Allergy Treatment Market Insights Forecast to 2030

Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stroke Treatment Market Insights Forecast to 2030

Global Proteinuria Treatment Market Insights Forecast to 2030

Global PD 1 and PD L1 Immunotherapy Market Insights Forecast to 2030

Global Skin Allergy Treatment Market Insights Forecast to 2030

Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Small Molecule Targeted Therapy Market Insights Forecast to 2030

Global Anti PD 1 MAb Market Insights Forecast to 2030

Tumor Immunotherapy Market

Global Antibodies in Oncology Market Research Report 2024

Global Immuno Oncology Service Market Research Report 2024

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Infusion Therapy Market Insights Forecast to 2030

RELATED REPORTS

Global Ultrasonics Technologies Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0L6392

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Health Self-monitoring Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4V7252

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global High-Acuity Information System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4O6282

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Marburgvirus Infection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36D6023

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions